Kontour Medical Technology Stock Revenue
| 688314 Stock | 29.78 0.16 0.53% |
Kontour Medical Technology fundamentals help investors to digest information that contributes to Kontour (Xian)'s financial success or failures. It also enables traders to predict the movement of Kontour Stock. The fundamental analysis module provides a way to measure Kontour (Xian)'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kontour (Xian) stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 316.3 M | 228.7 M |
Kontour | Revenue |
Kontour Medical Technology Company Revenue Analysis
Kontour (Xian)'s Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Kontour (Xian) Revenue | 275.03 M |
Most of Kontour (Xian)'s fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kontour Medical Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Kontour Total Revenue
Total Revenue |
|
Based on the latest financial disclosure, Kontour Medical Technology reported 275.03 M of revenue. This is 96.39% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The revenue for all China stocks is 97.09% higher than that of the company.
Kontour Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kontour (Xian)'s direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kontour (Xian) could also be used in its relative valuation, which is a method of valuing Kontour (Xian) by comparing valuation metrics of similar companies.Kontour Medical is currently under evaluation in revenue category among its peers.
Kontour Fundamentals
| Current Valuation | 2.08 B | ||||
| Price To Book | 3.79 X | ||||
| Price To Sales | 7.85 X | ||||
| Revenue | 275.03 M | ||||
| EBITDA | 106.76 M | ||||
| Net Income | 75.51 M | ||||
| Total Debt | 37.97 M | ||||
| Cash Flow From Operations | 85.22 M | ||||
| Total Asset | 675.79 M | ||||
| Retained Earnings | 164.9 M | ||||
| Working Capital | 346.95 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 675.79 M |
About Kontour (Xian) Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kontour Medical Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kontour (Xian) using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kontour Medical Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Other Information on Investing in Kontour Stock
Kontour (Xian) financial ratios help investors to determine whether Kontour Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kontour with respect to the benefits of owning Kontour (Xian) security.